↓ Skip to main content

Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution

Overview of attention for article published in BMC Pharmacology and Toxicology, December 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case report: inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution
Published in
BMC Pharmacology and Toxicology, December 2014
DOI 10.1186/2050-6511-15-69
Pubmed ID
Authors

Ashraf G Madian, Arun Panigrahi, Minoli A Perera, Navin Pinto

Abstract

Tacrolimus is an immunosuppressive drug that is used to lower the activity of the patient's immune system to prevent organ rejection. Unfortunately, there is limited data regarding the therapeutic equivalency of generic tacrolimus formulations especially in children. We report the case of a pediatric patient having an inability to achieve a therapeutic trough level for tacrolimus after conversion from brand name to the generic formulation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 4%
Unknown 27 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 21%
Student > Bachelor 4 14%
Student > Master 4 14%
Student > Ph. D. Student 3 11%
Student > Postgraduate 3 11%
Other 5 18%
Unknown 3 11%
Readers by discipline Count As %
Medicine and Dentistry 11 39%
Pharmacology, Toxicology and Pharmaceutical Science 7 25%
Nursing and Health Professions 3 11%
Sports and Recreations 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 4 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2015.
All research outputs
#13,644,834
of 24,337,175 outputs
Outputs from BMC Pharmacology and Toxicology
#168
of 462 outputs
Outputs of similar age
#175,256
of 370,188 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#8
of 18 outputs
Altmetric has tracked 24,337,175 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 462 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.